Loading...

California Nanotechnologies

TSXV:CNO
Snowflake Description

Questionable track record with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CNO
TSXV
CA$3M
Market Cap
  1. Home
  2. CA
  3. Materials
Company description

California Nanotechnologies Corp. engages in the research, development, and production of nano-structured components and materials. The last earnings update was 94 days ago. More info.


Add to Portfolio Compare Print
  • California Nanotechnologies has significant price volatility in the past 3 months.
CNO Share Price and Events
7 Day Returns
38.5%
TSXV:CNO
-0.1%
CA Chemicals
0.9%
CA Market
1 Year Returns
28.6%
TSXV:CNO
6.4%
CA Chemicals
-0.2%
CA Market
CNO Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
California Nanotechnologies (CNO) 38.5% 50% 80% 28.6% 12.5% -43.8%
CA Chemicals -0.1% 0.1% 14.9% 6.4% 41.7% -9.2%
CA Market 0.9% 2.2% 10.5% -0.2% 15.7% 4.9%
1 Year Return vs Industry and Market
  • CNO outperformed the Chemicals industry which returned 6.4% over the past year.
  • CNO outperformed the Market in Canada which returned -0.2% over the past year.
Price Volatility
CNO
Industry
5yr Volatility vs Market
Related Companies

Value

 Is California Nanotechnologies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for California Nanotechnologies. This is due to cash flow or dividend data being unavailable. The share price is CA$0.09.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for California Nanotechnologies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are California Nanotechnologies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSXV:CNO PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-11-30) in USD $0.00
TSXV:CNO Share Price ** TSXV (2019-03-15) in CAD CA$0.09
TSXV:CNO Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.75 $0.07
Canada Chemicals Industry PE Ratio Median Figure of 6 Publicly-Listed Chemicals Companies 9.05x
Canada Market PE Ratio Median Figure of 542 Publicly-Listed Companies 14.84x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of California Nanotechnologies.

TSXV:CNO PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:CNO Share Price ÷ EPS (both in USD)

= 0.07 ÷ 0.00

49.96x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • California Nanotechnologies is overvalued based on earnings compared to the CA Chemicals industry average.
  • California Nanotechnologies is overvalued based on earnings compared to the Canada market.
Price based on expected Growth
Does California Nanotechnologies's expected growth come at a high price?
Raw Data
TSXV:CNO PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 49.96x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Chemicals Industry PEG Ratio Median Figure of 49 Publicly-Listed Chemicals Companies 1.45x
Canada Market PEG Ratio Median Figure of 251 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for California Nanotechnologies, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on California Nanotechnologies's assets?
Raw Data
TSXV:CNO PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-11-30) in USD $-0.04
TSXV:CNO Share Price * TSXV (2019-03-15) in CAD CA$0.09
TSXV:CNO Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.75 $0.07
Canada Chemicals Industry PB Ratio Median Figure of 29 Publicly-Listed Chemicals Companies 1.38x
Canada Market PB Ratio Median Figure of 2,348 Publicly-Listed Companies 1.57x
TSXV:CNO PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:CNO Share Price ÷ Book Value per Share (both in USD)

= 0.07 ÷ -0.04

-1.89x

* Primary Listing of California Nanotechnologies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • California Nanotechnologies has negative assets, we can't compare the value of its assets to the CA Chemicals industry average.
X
Value checks
We assess California Nanotechnologies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. California Nanotechnologies has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is California Nanotechnologies expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as California Nanotechnologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28.7%
Expected Chemicals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is California Nanotechnologies expected to grow at an attractive rate?
  • Unable to compare California Nanotechnologies's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare California Nanotechnologies's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare California Nanotechnologies's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
TSXV:CNO Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 28.7%
Canada Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.2%
Canada Market Earnings Growth Rate Market Cap Weighted Average 17.9%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSXV:CNO Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSXV:CNO Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-11-30 1 0 0
2018-08-31 1 0 0
2018-05-31 1 0 0
2018-02-28 1 0 0
2017-11-30 0 0 0
2017-08-31 1 0 0
2017-05-31 1 0 0
2017-02-28 1 0 0
2016-11-30 1 0 0
2016-08-31 0 0 0
2016-05-31 0 0 0
2016-02-29 0 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if California Nanotechnologies is high growth as no earnings estimate data is available.
  • Unable to determine if California Nanotechnologies is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSXV:CNO Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from California Nanotechnologies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSXV:CNO Past Financials Data
Date (Data in USD Millions) EPS *
2018-11-30 0.00
2018-08-31 0.00
2018-05-31 0.00
2018-02-28 0.00
2017-11-30 -0.01
2017-08-31 -0.01
2017-05-31 -0.01
2017-02-28 -0.01
2016-11-30 -0.01
2016-08-31 0.00
2016-05-31 -0.01
2016-02-29 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if California Nanotechnologies will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. California Nanotechnologies's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Materials companies here
  2. California Nanotechnologies's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess California Nanotechnologies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
California Nanotechnologies has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has California Nanotechnologies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare California Nanotechnologies's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • California Nanotechnologies has delivered over 20% year on year earnings growth in the past 5 years.
  • California Nanotechnologies has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • California Nanotechnologies has become profitable in the last year making it difficult to compare the North America Chemicals industry average.
Earnings and Revenue History
California Nanotechnologies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from California Nanotechnologies Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSXV:CNO Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-11-30 0.79 0.04 0.25 0.00
2018-08-31 0.71 -0.03 0.27 0.00
2018-05-31 0.61 -0.07 0.29 0.01
2018-02-28 0.55 -0.05 0.34 0.02
2017-11-30 0.43 -0.26 0.47 0.03
2017-08-31 0.53 -0.24 0.46 0.03
2017-05-31 0.56 -0.19 0.44 0.02
2017-02-28 0.54 -0.27 0.45 0.02
2016-11-30 0.57 -0.19 0.45 0.03
2016-08-31 0.45 -0.14 0.42 0.04
2016-05-31 0.43 -0.17 0.43 0.05
2016-02-29 0.43 -0.17 0.43 0.04
2015-11-30 0.38 -0.21 0.38 0.03
2015-08-31 0.32 -0.35 0.46 0.02
2015-05-31 0.29 -0.34 0.53 0.02
2015-02-28 0.35 -0.33 0.56 0.02
2014-11-30 0.47 -0.24 0.60 0.02
2014-08-31 0.47 -0.23 0.57 0.03
2014-05-31 0.48 -0.25 0.49 0.05
2014-02-28 0.37 -0.30 0.42 0.07
2013-11-30 0.24 -0.44 0.40 0.08
2013-08-31 0.18 -0.50 0.38 0.09
2013-05-31 0.26 -0.54 0.45 0.09
2013-02-28 0.26 -0.53 0.46 0.09
2012-11-30 0.25 -0.51 0.47 0.10
2012-08-31 0.25 -0.46 0.43 0.09
2012-05-31 0.18 -0.46 0.36 0.09

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if California Nanotechnologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • California Nanotechnologies used its assets more efficiently than the CA Chemicals industry average last year based on Return on Assets.
  • It is difficult to establish if California Nanotechnologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess California Nanotechnologies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
California Nanotechnologies has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is California Nanotechnologies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up California Nanotechnologies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • California Nanotechnologies's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • California Nanotechnologies's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of California Nanotechnologies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • California Nanotechnologies has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from California Nanotechnologies Company Filings, last reported 3 months ago.

TSXV:CNO Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-11-30 -1.12 1.77 0.05
2018-08-31 -1.16 1.81 0.02
2018-05-31 -1.14 1.82 0.03
2018-02-28 -1.13 1.85 0.04
2017-11-30 -1.18 1.85 0.01
2017-08-31 -1.15 1.56 0.03
2017-05-31 -1.09 1.27 0.02
2017-02-28 -1.11 1.21 0.02
2016-11-30 -0.96 1.09 0.07
2016-08-31 -0.95 1.07 0.02
2016-05-31 -0.94 1.05 0.05
2016-02-29 -0.88 1.05 0.11
2015-11-30 -0.80 1.05 0.10
2015-08-31 -0.84 1.05 0.09
2015-05-31 -0.79 1.03 0.13
2015-02-28 -0.72 1.04 0.19
2014-11-30 -0.62 1.06 0.30
2014-08-31 -0.53 1.11 0.43
2014-05-31 -0.49 1.14 0.54
2014-02-28 -0.94 1.17 0.00
2013-11-30 -0.92 1.13 0.02
2013-08-31 -0.83 1.25 0.22
2013-05-31 -0.76 1.22 0.00
2013-02-28 -0.65 1.15 0.01
2012-11-30 -0.50 1.08 0.01
2012-08-31 -0.35 0.94 0.00
2012-05-31 -0.26 0.85 0.02
  • California Nanotechnologies has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if California Nanotechnologies's debt level has increased considering it has negative shareholder equity.
  • Debt is not well covered by operating cash flow (8.9%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 1.3x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess California Nanotechnologies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. California Nanotechnologies has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is California Nanotechnologies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from California Nanotechnologies dividends.
If you bought CA$2,000 of California Nanotechnologies shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate California Nanotechnologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate California Nanotechnologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSXV:CNO Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 55 Stocks 2.3%
Canada Market Average Dividend Yield Market Cap Weighted Average of 331 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as California Nanotechnologies has not reported any payouts.
  • Unable to verify if California Nanotechnologies's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of California Nanotechnologies's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as California Nanotechnologies has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess California Nanotechnologies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can California Nanotechnologies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. California Nanotechnologies has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of California Nanotechnologies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Eric Eyerman
CEO Bio

Mr. Eric Eyerman serves as Chief Executive Officer, Chief Operating Officer and Director of California Nanotechnologies Corp. Prior to that he has also served as its Interim Chief Executive Officer. Eric Eyerman is a chemical engineer from Rutgers University in New Jersey.

CEO Compensation
  • Insufficient data for Eric to compare compensation growth.
  • Insufficient data for Eric to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team

David Grant

TITLE
Chairman & Interim CFO
AGE
65

Eric Eyerman

TITLE
CEO, COO & Director

Mikel Damke

TITLE
Executive Assistant to the Chief Executive Officer
Board of Directors Tenure

Average tenure of the California Nanotechnologies board of directors in years:

3.6
Average Tenure
  • The tenure for the California Nanotechnologies board of directors is about average.
Board of Directors

David Grant

TITLE
Chairman & Interim CFO
AGE
65

Eric Eyerman

TITLE
CEO, COO & Director
TENURE
0.6 yrs

Roger Dent

TITLE
Independent Director
COMPENSATION
$2K
TENURE
4.9 yrs

Sébastien Goulet

TITLE
Director
AGE
48
TENURE
3.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
X
Management checks
We assess California Nanotechnologies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. California Nanotechnologies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Volatility 101: Should California Nanotechnologies (CVE:CNO) Shares Have Dropped 48%?

Check out our latest analysis for California Nanotechnologies. … With just US$785,562 worth of revenue in twelve months, we don't think the market considers California Nanotechnologies to have proven its business plan. … You can see in the image below, how California Nanotechnologies's cash and debt levels have changed over time (click to see the values)

Simply Wall St -

Does California Nanotechnologies Corp. (CVE:CNO) Have A Particularly Volatile Share Price?

Every stock in the market is exposed to this volatility, which is linked to the fact that stocks prices are correlated in an efficient market. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market.

Simply Wall St -

What Percentage Of California Nanotechnologies Corp (CVE:CNO) Shares Do Insiders Own?

If you want to know who really controls California Nanotechnologies Corp (CVE:CNO), then you'll have to look at the makeup of its share registry. … California Nanotechnologies is a smaller company with a market capitalization of CA$1m, so it may still be flying under the radar of many institutional investors. … institutional investors have not yet purchased much of the company.

Simply Wall St -

How Should You Think About California Nanotechnologies Corp's (CVE:CNO) Risks?

It seems as though there is an inconsistency in risks portrayed by CNO’s size and industry relative to its actual beta value. … I examine CNO’s ratio of fixed assets to total assets to see whether the company is highly exposed to the risk of this type of constraint. … Thus, we can expect CNO to be more volatile in the face of market movements, relative to its peers of similar size but with a lower proportion of fixed assets on their books.

Simply Wall St -

What Does California Nanotechnologies Corp's (CVE:CNO) Ownership Structure Look Like?

In this article, I'm going to take a look at California Nanotechnologies Corp’s (TSXV:CNO) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. … Private Company Ownership Potential investors in CNO should also look at another important group of investors: private companies, with a stake of 17.51%, who are primarily invested because of strategic and capital gain interests. … Thus, potential investors should look into these business relations and check how it can impact long-term shareholder returns.Next Steps: Institutional ownership level and composition in CNO is not high nor active enough to significantly impact its investment thesis.

Simply Wall St -

With A -38.29% Earnings Drop, Is California Nanotechnologies Corp's (CVE:CNO) A Concern?

Measuring California Nanotechnologies Corp's (TSXV:CNO) track record of past performance is a valuable exercise for investors. … See our latest analysis for California Nanotechnologies How Did CNO's Recent Performance Stack Up Against Its Past? … TSXV:CNO Income Statement Mar 11th 18 We can further analyze California Nanotechnologies's loss by looking at what the industry has been experiencing over the past few years.

Simply Wall St -

Next Capital Raising For California Nanotechnologies Corp (CVE:CNO)?

See our latest analysis for California Nanotechnologies What is cash burn? … However, even with declining costs, the current level of cash is not enough to sustain California Nanotechnologies’s operations and the company may need to come to market to raise more capital within the year. … Although this is a relatively simplistic calculation, and California Nanotechnologies may continue to reduce its costs further or raise debt capital instead of coming to equity markets, the analysis still helps us understand how sustainable the California Nanotechnologies’s operation is, and when things may have to change.

Simply Wall St -

Before You Buy California Nanotechnologies Corp's (CVE:CNO), You Should Consider This

California Nanotechnologies has a beta of 1.16, which means that the percentage change in its stock value will be higher than the entire market in times of booms and busts. … A high level of beta means investors face higher risk associated with potential gains and losses driven by market movements. … How CNO's assets could affect its beta An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive.

Simply Wall St -

Is California Nanotechnologies Corp (CVE:CNO) A Basic Materials Leader?

In this article, I’ll take you through the sector growth expectations, as well as evaluate whether California Nanotechnologies is lagging or leading its competitors in the industry. … View our latest analysis for California Nanotechnologies What’s the catalyst for California Nanotechnologies's sector growth? … If your initial investment thesis is around the growth prospects of California Nanotechnologies, there are other chemicals companies that have delivered higher growth, and perhaps trading at a discount to the industry average.

Simply Wall St -

Who Owns Most Of California Nanotechnologies Corp (CVE:CNO)?

This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses. … This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. … Thus, investors should dig deeper into CNO's business relations with these companies and how it can affect shareholder returns in the long-term.What this means for you: Institutional ownership in CNO is not at a level that would concern investors.

Simply Wall St -

Company Info

Description

California Nanotechnologies Corp. engages in the research, development, and production of nano-structured components and materials. The company produces powders, billets, wires, and precision forged components from nano, near-nano, ultrafine, and conventional advanced materials. It offers cold forged parts, including fasteners, bolts, pins, caps, and other components; nano light alloy and nano grain powders, such as aluminum, aluminum alloys, titanium, titanium alloys, magnesium, and magnesium alloys, as well as nano alloy billets; nano super alloy powders; thermal spray powders comprising WC-based materials and titanium powders; and cemented carbides. The company also provides component design and manufacturing services, such as production of nano aerospace parts and components; machining and sinker EDM components; spark plasma sintering services; scanning electron microscopy and ion milling services; cryogenic milling services; controlled atmospheric handling services; high vacuum/high temperature degassing services; and spray drying services. It serves customers in aerospace, defense, automotive, medical, oil and gas, mining, sports and recreation, and other industries. California Nanotechnologies Corp. is headquartered in Cerritos, California.

Details
Name: California Nanotechnologies Corp.
CNO
Exchange: TSXV
Founded:
CA$2,828,726
31,430,296
Website: http://www.calnanocorp.com
Address: California Nanotechnologies Corp.
17220 Edwards Road,
Cerritos,
California, 90703,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV CNO Class A Common Shares TSX Venture Exchange CA CAD 05. Feb 2007
OTCPK CANO.F Class A Common Shares Pink Sheets LLC US USD 05. Feb 2007
Number of employees
Current staff
Staff numbers
0
California Nanotechnologies employees.
Industry
Specialty Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/17 23:55
End of day share price update: 2019/03/15 00:00
Last earnings filing: 2018/12/13
Last earnings reported: 2018/11/30
Last annual earnings reported: 2018/02/28


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.